JD Health

JD Health is the online drugstore belonging to JD.com company.

History

2020: Entry into the exchange

At the beginning of December, 2020 the JD Health company, medical division of the Chinese giant of e-commerce JD.com, carried out primary public placement of the actions at the exchange in Hong Kong. The company produced 381.9 million actions at the price of 70.58 Hong Kong dollars for an action ($9.11) to attract up to $3.5 billion.

JD Health placed shares on the upper bound of the announced price range - from 62.8 to 70.58 Hong Kong dollars. The company is going to sell 381.9 million papers (12.2% of the capital), and proceeding from it the market value of the company is $28.5 billion.

The online drugstore of JD Health went public

JD Health entry into the market marks one more large victory for stock exchange in Hong Kong where eventually all large Chinese technology companies get. So, JD.com, JD Health parent company, carried out secondary share placing in Hong Kong in June, 2020, as well as one more Chinese Internet company - NetEase.

Six anchor investors, including sovereign investment fund of Singapore, Blackrock, Tiger Global and Hillhouse which can acquire shares for the amount to $1.35 billion, i.e. more than a third of all volume of placement will take part in initial public offering. The IPO size can reach $4 billion if underwriters use the option for additional share purchase. Bank of America, Haitong International Securities Group and UBS Group are among organizers of placement.

JD.com possesses about 78% of JD Health. Business of this company is concentrated on online services of health care, such as consultations with doctors and also on services of Internet drugstore. Owing to a koronavirusny pandemic JD Health revenue in the first half of 2020 grew almost practically twice.^[1]

Notes